Literature DB >> 2181945

In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.

P J Velthuis1, L Kater, I van der Tweel, F G Meyling, R H Derksen, R J Hené, J A van Geutselaar, H Baart de la Faille.   

Abstract

Immunofluorescence microscopy of the skin has disclosed antibodies bound to epidermal cell nuclei in several connective tissue disorders. To establish the diagnostic potential of this phenomenon the results of immunofluorescence microscopy of biopsy specimens from 1651 subjects with various diseases and from 315 patients with systemic connective tissue disorders and related diseases were reviewed. It was found that the predictive value of the phenomenon for the presence of a systemic connective tissue disorder was, in general, 88%. Except for the homogeneous and thready patterns, which seldom appear, but are specific for SLE, in vivo antinuclear antibody (ANA) does not discriminate better between the various disorders than do serum antibodies. The presence of in vivo ANA in the skin was related to serum antibodies against non-histone nucleoproteins, but not to anti-dsDNA antibodies. Combined with the finding that antibodies against non-histone nucleoproteins can bind on the surface of human keratinocytes, this suggests that ANA of the skin occurs in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181945      PMCID: PMC1004013          DOI: 10.1136/ard.49.3.163

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Observations on the in vivo reaction of antinuclear antibodies with epidermal cells.

Authors:  G T Izuno
Journal:  Br J Dermatol       Date:  1978-04       Impact factor: 9.302

3.  In-vivo nuclear localization of immunoglobulins in clinically normal skin in systemic and procainamide-induced lupus erythematosus.

Authors:  E H de la Baart Faille-Kuyper
Journal:  Neth J Med       Date:  1974       Impact factor: 1.422

4.  Mixed connective tissue disease syndrome.

Authors:  J N Gilliam; S D Prystowsky
Journal:  Arch Dermatol       Date:  1977-05

5.  In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.

Authors:  C G Kallenberg; M C de Jong; T M Walstra; S Kardaun; T H The
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

6.  Mixed connective tissue disease characterized by speckled epidermal nuclear IgG deposition in normal skin.

Authors:  C B Bentley-Phillips; T M Geake
Journal:  Br J Dermatol       Date:  1980-05       Impact factor: 9.302

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Epidermal nucleolar IgG deposition in clinically normal skin: clinical and serologic features of eight patients.

Authors:  S D Prystowsky; J N Gilliam; D L Tuffanelli
Journal:  Arch Dermatol       Date:  1978-04

9.  In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.

Authors:  J V Wells; J Webb; M Van Deventer; B Fry; K M Pollard; J Raftos; W Monk; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.

Authors:  G Reimer; U Huschka; J Keller; R Kammerer; O P Hornstein
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

View more
  3 in total

1.  Immunofluorescence microscopy of healthy skin from patients with systemic lupus erythematosus: more than just the lupus band.

Authors:  P J Velthuis; L Kater; I van der Tweel; H B de la Faille; W A van Vloten
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Clinicopathological Significance among Patients with In vivo Epidermal Nuclear Staining by Direct Immunofluorescence Study.

Authors:  Wararat Sirikudta; Papapit Tuchinda; Leena Chularojanamontri; Kanokvalai Kulthanan; Samruay Pinkaew
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494

3.  Enhanced diagnostic immunofluorescence using biopsies transported in saline.

Authors:  Robert M Vodegel; Marcelus C J M de Jong; Hillegonda J Meijer; Marijn B Weytingh; Hendri H Pas; Marcel F Jonkman
Journal:  BMC Dermatol       Date:  2004-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.